Canada Pension Plan Investment Board’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Canada Pension Plan Investment Board's TXG Position: Q2 2026 in Review
Canada Pension Plan Investment Board reduced its 10x Genomics (TXG) stake by 46% in Q2 2026, selling an estimated $1M and leaving 44,600 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #929.
Canada Pension Plan Investment Board first reported a position in TXG in Q1 2021 and has held it in 15 quarters since. The position peaked at $3.74M in Q4 2025. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Canada Pension Plan Investment Board held 44,600 shares of 10x Genomics worth $1.71M as of Q2 2026.
- Canada Pension Plan Investment Board sold 38,300 10x Genomics shares in Q2 2026, an estimated $1M.
- 10x Genomics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #929 holding.
- Canada Pension Plan Investment Board first reported a position in 10x Genomics in Q1 2021 and has held it in 15 quarters since.
- Canada Pension Plan Investment Board's 10x Genomics position peaked at $3.74M in Q4 2025.
- 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.